GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSL:VISTN) » Definitions » Other Operating Expense

Vistin Pharma ASA (OSL:VISTN) Other Operating Expense : kr199.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Other Operating Expense?

Vistin Pharma ASA's Other Operating Expense for the three months ended in Mar. 2025 was kr49.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr199.2 Mil.

Vistin Pharma ASA's quarterly Other Operating Expense increased from Sep. 2024 (kr51.2 Mil) to Dec. 2024 (kr51.2 Mil) but then declined from Dec. 2024 (kr51.2 Mil) to Mar. 2025 (kr49.0 Mil).

Vistin Pharma ASA's annual Other Operating Expense increased from Dec. 2022 (kr74.1 Mil) to Dec. 2023 (kr107.5 Mil) and increased from Dec. 2023 (kr107.5 Mil) to Dec. 2024 (kr112.8 Mil).


Vistin Pharma ASA Other Operating Expense Historical Data

The historical data trend for Vistin Pharma ASA's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Other Operating Expense Chart

Vistin Pharma ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.38 81.22 74.08 107.55 112.84

Vistin Pharma ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.06 47.84 51.16 51.18 48.98

Vistin Pharma ASA Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr199.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vistin Pharma ASA Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Vistin Pharma ASA Business Description

Traded in Other Exchanges
Address
Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines